Basic Information
RNALocate ID: RLID-D:11000270
RNA Symbol: hsa-miR-17-3p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-17-3p
RNA ID: miRBase:MIMAT0000071
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
Tissue/Cell Line: Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
Database: EVmiRNA
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001277 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:11000698 Exosome Plasma 19289371
RLID:11000699 Exosome Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11000700 Exosome B cell line (Raji)|Primary dendritic cells|T cell line (J77) 21505438
RLID:11000701 Exosome Breast milk 22211110
RLID:11000702 Exosome Brain tissue 23382797
RLID:11000703 Exosome Plasma 23663360
RLID:11000704 Microvesicle Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11000705 Microvesicle Liver resident stem cells 20668554
RLID:11000706 Microvesicle Seminal plasma 23539611
RLID-D:11001155 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-17-3p Splenic marginal zone lymphoma MNDR-E-MI-19005
MNDR hsa-miR-17-3p Oral squamous cell carcinoma MNDR-E-MI-19006
MNDR hsa-miR-17-3p Large cell neuroendocrine cancer MNDR-E-MI-19007
MNDR hsa-miR-17-3p Medulloblastoma MNDR-E-MI-19008
MNDR hsa-miR-17-3p Ovarian clear cell carcinoma MNDR-E-MI-19009
MNDR hsa-miR-17-3p Lymphoma MNDR-E-MI-19010
MNDR hsa-miR-17-3p Lymphoma non-hodgkin MNDR-E-MI-19011
MNDR hsa-miR-17-3p Estrogen-receptor positive breast cancer MNDR-E-MI-19012
MNDR hsa-miR-17-3p Estrogen-receptor negative breast cancer MNDR-E-MI-19013
MNDR hsa-miR-17-3p Progesterone-receptor positive breast cancer MNDR-E-MI-19014
MNDR hsa-miR-17-3p Progesterone-receptor negative breast cancer MNDR-E-MI-19015
MNDR hsa-miR-17-3p Her2-receptor positive breast cancer MNDR-E-MI-19016
MNDR hsa-miR-17-3p Breast cancer luminal MNDR-E-MI-19017
MNDR hsa-miR-17-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-19018
MNDR hsa-miR-17-3p Thyroid carcinoma anaplastic MNDR-E-MI-19019
MNDR hsa-miR-17-3p Prostate cancer MNDR-E-MI-19020
MNDR hsa-miR-17-3p Gastric cancer MNDR-E-MI-19021
MNDR hsa-miR-17-3p Gastric lymphoma MNDR-E-MI-19022
MNDR hsa-miR-17-3p Alzheimer disease MNDR-E-MI-19023
MNDR hsa-miR-17-3p Esophageal carcinoma MNDR-E-MI-19024
MNDR hsa-miR-17-3p Head and neck cancer MNDR-E-MI-19025
MNDR hsa-miR-17-3p Cardiovascular disease MNDR-E-MI-19026
MNDR hsa-miR-17-3p Lung cancer MNDR-E-MI-19027
MNDR hsa-miR-17-3p Parkinson disease MNDR-E-MI-19028
MNDR hsa-miR-17-3p Basal-like breast cancer MNDR-E-MI-19029
MNDR hsa-miR-17-3p Pancreatic cancer MNDR-E-MI-19030
MNDR hsa-miR-17-3p Melanoma MNDR-E-MI-19031
MNDR hsa-miR-17-3p Rectum adenocarcinoma MNDR-E-MI-19032
MNDR hsa-miR-17-3p Nephroblastoma MNDR-E-MI-19033
MNDR hsa-miR-17-3p Colon cancer MNDR-E-MI-19034
MNDR hsa-miR-17-3p Colon adenocarcinoma MNDR-E-MI-19035
MNDR hsa-miR-17-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-19036
MNDR hsa-miR-17-3p Prostate adenocarcinoma MNDR-E-MI-19037
MNDR hsa-miR-17-3p Carcinoma ductal breast MNDR-E-MI-19038
MNDR hsa-miR-17-3p Glioblastoma MNDR-E-MI-19039
MNDR hsa-miR-17-3p Malignant glioma MNDR-E-MI-19040
MNDR hsa-miR-17-3p Amyotrophic lateral sclerosis MNDR-E-MI-19041
MNDR hsa-miR-17-3p Osteosarcoma MNDR-E-MI-19042
MNDR hsa-miR-17-3p Liposarcoma MNDR-E-MI-19043
MNDR hsa-miR-17-3p Uterine cancer MNDR-E-MI-19044
MNDR hsa-miR-17-3p Gastric adenocarcinoma MNDR-E-MI-19045
MNDR hsa-miR-17-3p Cervical squamous cell carcinoma MNDR-E-MI-19046
MNDR hsa-miR-17-3p Lung squamous cell carcinoma MNDR-E-MI-19047
MNDR hsa-miR-17-3p Lung adenocarcinoma MNDR-E-MI-19048
MNDR hsa-miR-17-3p Thyroid carcinoma MNDR-E-MI-19049
MNDR hsa-miR-17-3p Bladder urothelial carcinoma MNDR-E-MI-19050
MNDR hsa-miR-17-3p Pancreatic adenocarcinoma MNDR-E-MI-19051
MNDR hsa-miR-17-3p Carcinoma renal cell MNDR-E-MI-19052
MNDR hsa-miR-17-3p Kidney renal papillary cell carcinoma MNDR-E-MI-19053
MNDR hsa-miR-17-3p Clear cell renal cell carcinoma MNDR-E-MI-19054
MNDR hsa-miR-17-3p Cholangiocarcinoma MNDR-E-MI-19055
MNDR hsa-miR-17-3p Lung small cell carcinoma MNDR-E-MI-19056
MNDR hsa-miR-17-3p Stomach carcinoma MNDR-E-MI-19057
MNDR hsa-miR-17-3p Fibromyalgia MNDR-E-MI-19058
MNDR hsa-miR-17-3p Breast invasive carcinoma MNDR-E-MI-19059
MNDR hsa-miR-17-3p Hepatocellular carcinoma MNDR-E-MI-19060
MNDR hsa-miR-17-3p B-cell lymphoma MNDR-E-MI-19061
MNDR hsa-miR-17-3p Rheumatoid arthritis MNDR-E-MI-19062
MNDR hsa-miR-17-3p T-cell leukemia MNDR-E-MI-19063
MNDR hsa-miR-17-3p Retinoblastoma MNDR-E-MI-19064
MNDR hsa-miR-17-3p Hodgkin lymphoma MNDR-E-MI-19065
MNDR hsa-miR-17-3p Burkitt lymphoma MNDR-E-MI-19066
MNDR hsa-miR-17-3p Lymphosarcoma MNDR-E-MI-19067
MNDR hsa-miR-17-3p Tonsil cancer MNDR-E-MI-19068
MNDR hsa-miR-17-3p Acute myelogenous leukemia MNDR-E-MI-19069
MNDR hsa-miR-17-3p Colorectal cancer MNDR-E-MI-19070
MNDR hsa-miR-17-3p Nasopharynx carcinoma MNDR-E-MI-19071
MNDR hsa-miR-17-3p Acute lymphocytic leukemia MNDR-E-MI-19072
MNDR hsa-miR-17-3p Ependymoma MNDR-E-MI-19073
MNDR hsa-miR-17-3p Nasopharyngeal cancer MNDR-E-MI-19074
MNDR hsa-miR-17-3p Prostatic neoplasms MNDR-E-MI-19075
MNDR hsa-miR-17-3p Arsenic poisoning MNDR-E-MI-19076
MNDR hsa-miR-17-3p Stroke lacunar MNDR-E-MI-19077
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABHD13 Homo sapiens RR00025328
TOP